Adaptive Biotechnologies Corporation (ADPT)
NASDAQ · Healthcare
Adaptive Biotechnologies Corporation Price to FCF Ratio 2019–2026
Price to free cash flow (P/FCF) ratio for Adaptive Biotechnologies Corporation (ADPT): market cap divided by trailing twelve-month free cash flow. As of September 30, 2020 it is 34.15.
From: 06/30/2019To: 03/31/2026
Stock Price
TTM Free Cash Flow
Price to FCF
Adaptive Biotechnologies Corporation Price to FCF Ratio — FAQ
Adaptive Biotechnologies Corporation (ADPT) price to fcf ratio over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ADPT's price to fcf ratio history?
The chart and table above show Adaptive Biotechnologies Corporation's price to fcf ratio by year and by quarter, including the growth rate.